ES2051701T3 - Procedimiento para la obtencion de 1-desoxinojirimicina y sus n-derivados. - Google Patents

Procedimiento para la obtencion de 1-desoxinojirimicina y sus n-derivados.

Info

Publication number
ES2051701T3
ES2051701T3 ES87104555T ES87104555T ES2051701T3 ES 2051701 T3 ES2051701 T3 ES 2051701T3 ES 87104555 T ES87104555 T ES 87104555T ES 87104555 T ES87104555 T ES 87104555T ES 2051701 T3 ES2051701 T3 ES 2051701T3
Authority
ES
Spain
Prior art keywords
image
formula
alkalinically
desoxinojirimicina
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87104555T
Other languages
English (en)
Inventor
Theo Dr Schroder
Mathias Dr Stubbe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2051701T3 publication Critical patent/ES2051701T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

LA INVENCION SE REFIERE A UN NUEVO PROCEDIMIENTO PARA LA OBTENCION DE 1-DESOXINOJIRIMICINAS DE FORMULA (I) EN LA QUE R TIENE EL SIGNIFICADO QUE SE INDICA EN LA DESCRIPCION. LOS COMPUESTOS DE FORMULA (I) SON EXCELENTES INHIBIDORES DE ALFA-AMINOGLUCOSIDASA Y PUEDEN EMPLEARSE COMO MEDICAMENTOS ANTIDIABETICOS.
ES87104555T 1986-04-09 1987-03-27 Procedimiento para la obtencion de 1-desoxinojirimicina y sus n-derivados. Expired - Lifetime ES2051701T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863611841 DE3611841A1 (de) 1986-04-09 1986-04-09 Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten

Publications (1)

Publication Number Publication Date
ES2051701T3 true ES2051701T3 (es) 1994-07-01

Family

ID=6298252

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87104555T Expired - Lifetime ES2051701T3 (es) 1986-04-09 1987-03-27 Procedimiento para la obtencion de 1-desoxinojirimicina y sus n-derivados.

Country Status (11)

Country Link
US (1) US4806650A (es)
EP (1) EP0240868B1 (es)
JP (1) JPH085858B2 (es)
KR (1) KR950005196B1 (es)
AT (1) ATE104962T1 (es)
CA (1) CA1277624C (es)
DE (2) DE3611841A1 (es)
DK (1) DK172539B1 (es)
ES (1) ES2051701T3 (es)
HU (1) HU196819B (es)
IL (1) IL82120A (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5329025A (en) * 1988-09-21 1994-07-12 G. D. Searle & Co. 3-azido compound
US5256788A (en) * 1989-02-13 1993-10-26 Nippon Shinyaku Co. Ltd. Moranoline derivatives and their production and the use of moranoline and its derivatives as a stabilizing agent for enzymes
ATE129997T1 (de) * 1989-07-27 1995-11-15 Monsanto Co Glykosidasehemmende piperidinverbindungen.
DE3936295A1 (de) * 1989-11-01 1991-05-02 Bayer Ag Verfahren zur herstellung von zwischenprodukten und zur synthese von n-(2-hydroxyethyl)-2-hydroxymethyl-3,4,5-trihydroxypiperidine
US5151519A (en) * 1990-05-07 1992-09-29 G. D. Searle & Co. Process for the preparation of 1,5-(alkylimino)-1,5-dideoxy-d-glucitol and derivatives thereof
WO1992000277A1 (fr) * 1990-06-29 1992-01-09 Nippon Shinyaku Co., Ltd. Derive de piperidine
ATE137266T1 (de) * 1990-09-20 1996-05-15 Monsanto Co Verfahren zur herstellung von n-substituiertem 1- deoxynojirimycin
DE4030040A1 (de) * 1990-09-22 1992-03-26 Bayer Ag Enzymatische de-acylierung von acyl-aminosorbosen und dessen verwendung bei der herstellung von 1-desoxynojirimicin
US5401645A (en) * 1992-03-16 1995-03-28 Monsanto Company Process for producing n-substituted polyhydroxy nitrogen-containing heterocycles utilizing acetobacteraceae and corynebacterium
US5258518A (en) * 1992-04-01 1993-11-02 G. D. Searle & Co. 2-substituted tertiary carbinol derivatives of deoxynojirimycin
AU1876095A (en) * 1994-02-25 1995-09-11 G.D. Searle & Co. Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
US20030100532A1 (en) 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
ES2216327T3 (es) 1997-11-10 2004-10-16 G.D. SEARLE & CO. Uso de iminoazucares alquilados para tratar la resistencia a multiples a farmacos.
JP2001525367A (ja) 1997-12-11 2001-12-11 ザ・チャンセラー・マスターズ・アンド・スカラーズ・オブ・ザ・ユニバーシティ・オブ・オックスフォード 膜関連ウイルス複製の阻害
US6465488B1 (en) 1997-12-11 2002-10-15 Chancellor, Masters & Scholars Of The University Of Oxford Inhibition of glycolipid biosynthesis
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
CA2319713C (en) 1998-02-12 2012-06-26 G.D. Searle & Co. Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
EP1173161A2 (en) 1999-02-12 2002-01-23 G.D. SEARLE & CO. Glucamine compounds for treating hepatitis virus infections
DE60039729D1 (de) 1999-02-12 2008-09-11 United Therapeutics Corp N-(8,8,8-Trifluorooctyl)-1,5-dideoxy-1,5-imino-D-glucitol zur Behandlung von Hepatitis-Virus-Infektionen
US7256005B2 (en) 1999-08-10 2007-08-14 The Chancellor, Masters And Scholars Of The University Of Oxford Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
US7816560B1 (en) 1999-08-10 2010-10-19 Thomas Jefferson University Long chain n-alkyl compounds and oxa-derivatives thereof
EP1261339A1 (en) * 2000-02-14 2002-12-04 Pharmacia Corporation Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
EP1181277A4 (en) 2000-03-31 2005-08-10 Univ Michigan State PROCESS FOR THE PREPARATION OF 1,5-DIDESOXY-1,5-IMINO HEXITOLS FROM OXIMES OR IMINES
US20030236489A1 (en) * 2002-06-21 2003-12-25 Baxter International, Inc. Method and apparatus for closed-loop flow control system
KR100520007B1 (ko) 2003-05-19 2005-10-11 건 식 조 혈압 강하 기능을 가지는 키토산 함유 소금의 제조방법
EP2932982B1 (en) 2005-05-17 2018-10-03 Amicus Therapeutics, Inc. A method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives
GB0614947D0 (en) * 2006-07-27 2006-09-06 Isis Innovation Epitope reduction therapy
WO2008088581A2 (en) 2006-08-02 2008-07-24 United Therapeutics Corporation Liposome treatment of viral infections
CA2666814A1 (en) * 2006-08-21 2008-05-29 United Therapeutics Corporation Combination therapy for treatment of viral infections
US8097728B2 (en) * 2007-04-30 2012-01-17 Philadelphia Health & Education Corporation Iminosugar compounds with antiflavirus activity
EP2282723A2 (en) * 2008-03-26 2011-02-16 University of Oxford Endoplasmic reticulum targeting liposomes
WO2010096764A1 (en) 2009-02-23 2010-08-26 United Therapeutics Corporation Iminosugars and methods of treating viral diseases
EP2400843B1 (en) * 2009-02-24 2015-11-11 United Therapeutics Corporation Iminosugars and methods of treating arenaviral infections
WO2010109330A2 (en) * 2009-03-27 2010-09-30 University Of Oxford Cholesterol level lowering liposomes
CA2765086C (en) 2009-06-12 2015-12-15 United Therapeutics Corporation Iminosugars and methods of treating bunyaviral and togaviral diseases
BR112012004676A2 (pt) * 2009-09-04 2019-09-24 United Therapeutics Corp método de tratar infecções orotomixovirais.
EP2473493B1 (en) * 2009-09-04 2014-04-30 United Therapeutics Corporation Methods of treating poxviral infections
KR20120081990A (ko) * 2009-09-04 2012-07-20 더 챈슬러 마스터즈 앤드 스칼라스 오브 더 유니버시티 오브 옥스포드 이미노당 및 필로바이러스 질환의 치료 방법
US20110136868A1 (en) * 2009-12-07 2011-06-09 University Of Oxford Agents for inhibiting osteoclastogenesis and/or osteoclast activation
WO2014017915A2 (en) 2012-07-27 2014-01-30 Universiteit Utrecht Holding B.V. Urea and guanidinium derivatives of iminosugars
JP6456393B2 (ja) 2013-09-16 2019-01-23 エマージェント バイロロジー エルエルシー デオキシノジリマイシン誘導体およびその使用方法
CN107207477B (zh) 2014-11-05 2022-11-01 伊美根特病毒学公司 用于治疗病毒性疾病的亚氨基糖
EP3318277A1 (en) 2016-11-04 2018-05-09 Institut du Cerveau et de la Moelle Epiniere-ICM Inhibitors of glucosylceramide synthase for the treatment of motor neuron diseases
JP2021514200A (ja) 2018-01-26 2021-06-10 浙江工▲業▼大学 グルコノバクターオキシダンスのソルビトールデヒドロゲナーゼおよびコエンザイムピロロキノリンキニーネの合成を促進する方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
GB2009152B (en) * 1977-11-10 1982-01-06 Nippon Shinyaku Co Ltd Method for producing moranoline and n-methylmoranoline
DE2834122A1 (de) * 1978-08-03 1980-02-14 Bayer Ag Verfahren zur herstellung von 6-amino-6-desoxy-l-sorbose
DE2853573A1 (de) * 1978-12-12 1980-07-03 Bayer Ag Herstellung von n-substituierten derivaten des l-desoxynojirimycins
DE2936240A1 (de) * 1979-09-07 1981-03-26 Bayer Ag, 51373 Leverkusen Verfahren zur herstellung bekannter und neuer 6-amino-6-desoxy-2,3-0-isopropyliden-(alpha)-l-sorbofuranose-derivate sowie neue zwischenprodukte des verfahrens
DE2942365A1 (de) * 1979-10-19 1981-05-14 Bayer Ag, 5090 Leverkusen 2-hydroxyalkyl-3,4,5-trihydroxy-(pi)-peridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3038901A1 (de) * 1980-10-15 1982-05-06 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins
DE3049446A1 (de) * 1980-12-30 1982-07-29 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 1,5-didesoxy-1,5-imino-d-glucitol und dessen n-derivaten

Also Published As

Publication number Publication date
IL82120A0 (en) 1987-10-30
CA1277624C (en) 1990-12-11
KR870010071A (ko) 1987-11-30
DE3789682D1 (de) 1994-06-01
EP0240868A2 (de) 1987-10-14
IL82120A (en) 1990-12-23
HUT43865A (en) 1987-12-28
US4806650A (en) 1989-02-21
ATE104962T1 (de) 1994-05-15
DE3611841A1 (de) 1987-10-15
EP0240868B1 (de) 1994-04-27
JPH085858B2 (ja) 1996-01-24
HU196819B (en) 1989-01-30
KR950005196B1 (ko) 1995-05-19
DK179387A (da) 1987-10-10
DK172539B1 (da) 1998-12-07
DK179387D0 (da) 1987-04-08
JPS62242663A (ja) 1987-10-23
EP0240868A3 (en) 1988-09-21

Similar Documents

Publication Publication Date Title
ES2051701T3 (es) Procedimiento para la obtencion de 1-desoxinojirimicina y sus n-derivados.
ES506237A0 (es) Procedimiento para la obtencion de derivados n-sustituidos de la 1-desoxijirimicina
ATE49195T1 (de) Herstellung von fibraten.
WO1988000042A1 (en) New 5-alkoxy-2,4-diamino-alkyl benzols, and hair tinting means using them
MX7012A (es) Procedimiento para preparar derivados de acido-cis,endo-2-azabiciclo-(5.3.0.)-decan-3-carboxilico.
ES2038623T3 (es) Procedimiento para preparar soluciones de oxazafosforinas con estabilidad mejorada.
ATE18054T1 (de) Derivate und reduktionsprodukte der dglucopyranosyl-alpha(1-5)-d-arabonsaeure, deren herstellung und verwendung.
ZA816259B (en) 2-(1,4-benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
ZA804367B (en) Mixtures of optical brighteners
PT81804B (pt) Processo para a preparacao de derivados de acido aminoacrilico
GB8432144D0 (en) Organic compounds
ES8707508A1 (es) Procedimiento para preparar derivados del estilbeno asimetricos conteniendo triazinilo
ES2071873T3 (es) Procedimiento para la preparacion de compuestos de 1-oxa-3,8-diaza-4-oxo-espiro(4,5)decano.
GB2175584A (en) Kojic acid derivatives and whitening cosmetics containing same
ZA876726B (en) 2-cyano-2-alkoximino-acetamides
DK114486D0 (da) Piperazinylmethyl-1,2,4-triazolylmethylcarbinoler, fremgangsmaade til fremstilling deraf og deres anvendelse som plantebeskyttelsesmidler
AU2172688A (en) Preparation of dien-1-ols, 9-hydroxydodec-10-enyl 1-tert-butyl ether and use thereof as an intermediate for synthesizing, 8,10-dodecadienol
ZA86543B (en) 2-alkoxycarbonylalkyl-3-oxo-5,6-diaryl-as-triazines having utility as therapeutics
PT84172B (pt) Processo para a preparacao de derivados da quinoleina
DK74594A (da) Fremgangsmåde til fremstilling af paroxetin eller et farmaceutisk acceptabelt salt deraf
SU1266156A1 (ru) 7-морфолинокумарины в качестве красителей для лазерной техники
DE58909563D1 (de) 3-Anilino-2-hydroxycarbonyl-4-thiophenessigsäuren
DE58909745D1 (de) Tetrahydro-4-phenylimino-3-thiophenessigsäuren

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 240868

Country of ref document: ES